MTHFR and stroke disorder: The effect of folic acid intervention also significantly reduced stroke risk in patients with the CC/CT MTHFR genotype [16] and in male patients with elevated serum calcium levels (albumin-corrected serum calcium ≥2.43 mmol/L) [13].